Study shows statistically significant positive findings in quality of
life
COPPELL, Texas--(BUSINESS WIRE)--Nov. 29, 2012--
Mannatech,
Incorporated (NASDAQ: MTEX),
the leading innovator and provider of naturally sourced supplements
based on Real
Food Technology® solutions, announced today the
publication of a study on The Effect of Dietary Supplements on the
Quality of Life of Retired Professional Football Players. The study was
published in the Global Journal of Health Science, Vol. 5, No. 2,
2013¹, e-Version FirstTM. http://www.ccsenet.org/journal/index.php/gjhs/article/view/21748
The open-label human clinical study showed that intake of Mannatech
products resulted in statistically significant positive findings of
general improvements in quality of life, satisfaction with health and
physical and mental health of retired professional football players who
used dietary supplements*†. The 15 retired football players
who participated in the study took Mannatech’s Ambrotose®
Complex powder, Omega-3
with Vitamin D3, Ambrotose
AO® capsules, PhytoMatrix®
caplets and PLUS™
caplets. Review of current scientific literature reveals that this
is one of the few studies conducted on dietary supplementation and
quality of life in retired football players using well-validated outcome
measures.
“We’re excited and encouraged by the results of this study,” explained
Dr. Robert A. Sinnott, CEO and Chief Science Officer for Mannatech, Inc.
“There have been various studies on dietary supplements released over
the past couple years that have seemed, at times, confusing and even
contradictory. The findings among this group of retired professional
football players is significant in that it measures what most people are
looking for in dietary supplements in the first place: an improved
quality of life. Our company is founded on providing advanced
nutritional technologies based on real-food sources that lead to
definitive improvements in well-being. This study clearly supports our
approach.”
The study was authored by Dr. Robert A. Sinnott, Dr. Rolando L. Maddela,
Dr. Sejong Bae and Dr. Talitha Best. Dr. Sinnott is the CEO and Chief
Science Officer at Mannatech, and Dr. Maddela is the Clinical Research
Administration Manager at Mannatech. Dr. Bae was a Professor in the
Department of Biostatistics at the University of North Texas Health
Science Center’s School of Public Health in Fort Worth, Texas (he is now
affiliated with University of Alabama at Birmingham); Dr. Best was a
Research Fellow in the Nutritional Physiology Research Center, Sansom
Institute for Health Research, University of South Australia, Adelaide,
South Australia (she is now affiliated with Central Queensland U. at
Bundaberg).
*This statement has not been evaluated by the Food and Drug
Administration. This product is not intended to diagnose, treat, cure or
prevent any disease.
†This study was funded by Mannatech, Incorporated.
¹ Sinnott, R.A., Maddela, R.L., Bae, S., & Best, T. The Effect of
Dietary Supplements on the Quality of Life of Retired Professional
Football Players. Global Journal of Health Science 2013; Vol.5,
No.2 (e-Version FirstTM). Published online November 22, 2012.
To learn more about Mannatech products, visit Mannatech.com.
Learn more about Mannatech science and related publications and studies
at MannatechScience.org.
About Mannatech
Mannatech, Incorporated, develops high-quality health, weight and
fitness, and skincare products that are based on the solid foundation of
nutritional science and development standards. Mannatech is dedicated to
its platform of Social Entrepreneurship based on the foundation of
promoting, aiding and optimizing nutrition where it is needed most
around the world. Mannatech’s proprietary products are available through
independent sales Associates around the globe including the United
States, Canada, South Africa, Australia, New Zealand, Austria, Denmark,
Germany, Norway, Sweden, the Netherlands, the United Kingdom, Japan,
Taiwan, Singapore, Estonia, Finland, the Republic of Ireland, Czech
Republic, the Republic of Korea, Mexico and Namibia. For more
information, visit Mannatech.com.
Please note: This release contains “forward-looking statements”
within the meaning of Section 27A of the Securities Act of 1933, as
amended, Section 21E of the Securities Exchange Act of 1934, as amended,
and the Private Securities Litigation Reform Act of 1995. These
forward-looking statements generally can be identified by use of phrases
or terminology such as “intend” or other similar words or the negative
of such terminology. Similarly, descriptions of Mannatech’s objectives,
strategies, plans, goals or targets contained herein are also considered
forward-looking statements. Mannatech believes this release should be
read in conjunction with all of its filings with the United States
Securities and Exchange Commission and cautions its readers that these
forward-looking statements are subject to certain events, risks,
uncertainties and other factors. Some of these factors include, among
others, Mannatech’s inability to attract and retain Associates and
Members, increases in competition, litigation, regulatory changes and
its planned growth into new international markets. Although Mannatech
believes that the expectations, statements and assumptions reflected in
these forward-looking statements are reasonable, it cautions readers to
always consider all of the risk factors and any other cautionary
statements carefully in evaluating each forward-looking statement in
this release, as well as those set forth in its latest Annual Report on
Form 10-K and Quarterly Report on Form 10-Q, and other filings filed
with the United States Securities and Exchange Commission, including its
current reports on Form 8-K. All of the forward-looking statements
contained herein speak only as of the date of this release.
Source: Mannatech, Incorporated
Mannatech, Incorporated
Brett Duncan, 972-471-7367
bduncan@mannatech.com